Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

How stress and anxiety change how people value rewards

Official title: Stress and Anxiety Effects on Valuation

Run by NYU Langone Health · NCT07252947 · Data updated 2026-11-12

This study will test whether stress, anxiety, and negative mood change how adults learn from and choose rewards, including a group with generalized anxiety disorder.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment200 (estimated)
SponsorNYU Langone Health
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedDecember 18, 2025
Main results expectedNovember 7, 2028
Study endsNovember 7, 2028
Registry record updatedOctober 30, 2026
Trial IDNCT07252947 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–65 who speak, read, and write English and can provide informed consent; Aims 1–3 enroll psychiatrically and neurologically healthy volunteers, while Aim 4 enrolls adults with a diagnosis of generalized anxiety disorder.

Probably not a fit

People with high blood pressure or heart conditions, diabetes or metabolic disorders, pregnancy, those taking corticosteroids or beta-blockers, or those with current neurologic or psychiatric disease are excluded and would not be eligible to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants aged 18–65 will undergo a lab stress induction (the Socially Evaluated Cold Pressor Task) or a non-stressful control task and then complete decision-making tasks that measure reward adaptation and emotion prediction errors. The primary aim compares two forms of reward-based decision adaptation and emotion prediction errors under differing levels of stress and anxiety. Secondary analyses will relate individual differences (e.g., symptom levels) to these decision-making variables. Standard exclusions apply (e.g., serious medical or psychiatric conditions, certain medications, pregnancy) and one aim specifically enrolls participants diagnosed with generalized anxiety disorder.

Why it matters

Potential benefit: If successful, the results could help tailor treatments that target altered learning and decision-making in people with anxiety.

How similar studies have gone: Prior lab studies using the SECPT and related stress manipulations have shown that acute stress can alter learning and reward processing, so this work builds on established methods rather than being entirely novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Aims 1-3: To be eligible for participation in this study, an individual must meet all of the following criteria:

* 18-65 years of age
* Able to speak, read, and write fluently in English
* Be willing and able to follow study procedures and provide informed consent.

Aim 4: To be eligible for participation in this study, an individual must meet all of the following criteria:

* 18-65 years of age
* Diagnosis of GAD
* Able to speak, read, and write fluently in English
* Be willing and able to follow study procedures and provide informed consent.

Exclusion Criteria:

Aims 1-3: Individuals will be excluded from participation if any of the following criteria are met:

* History of or medication for neurologic or psychiatric disease
* High-blood pressure or heart condition
* Diabetes, food allergies, metabolic disorders or history of eating disorder
* Use of corticosteroids or beta-blockers
* Pregnancy

Aim 4: Individuals will be excluded from participation if any of the following criteria are met:

* High-blood pressure or heart condition
* Diabetes, food allergies, metabolic disorders or history of eating disorder
* Use of corticosteroids or beta-blockers
* Lifetime history of bipolar disorder or any psychotic disorder; substance use disorder in past 3 months; eating disorder in past 6 months; current major depressive disorder (past is allowed)
* Active suicidal ideation with plan and intent (indicated by score \>=4 on the Columbia Suicide Severity Scale)
* Not on stable dose of psychiatric medication for at least 4 weeks prior to study participation
* Pregnancy

Where it's running

  • NYU Langone Health
    New York, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Medial unloader brace after root repair

    This study tests whether using a medial unloader brace after arthroscopic medial meniscus posterior root repair helps healing and improves knee outcomes.

    Recruiting NYU Langone Health · New York, New York · NCT07909369

  • MAC-STILA: a feasibility test for hip fracture surgery anesthesia

    This trial tests whether combining monitored anesthesia care with soft tissue infiltration using local anesthesia can reduce post-operative delirium in adults 65 and older undergoing hip fracture repair.

    Recruiting NYU Langone Health · Evanston, Illinois and 4 other locations · NCT07897656

  • Osimertinib with Cyclosporine A for EGFR-mutant NSCLC

    This phase II study tests whether adding cyclosporine A to osimertinib helps people with EGFR-mutant metastatic NSCLC who still have detectable tumor DNA in blood.

    Recruiting Phase 2 NYU Langone Health · New York, New York · NCT07874490

  • Histotripsy with chemotherapy and immunotherapy for biliary tract cancer

    This pilot test will see if adding histotripsy to chemoimmunotherapy is safe and feasible for adults with biliary tract cancer.

    Recruiting NYU Langone Health · New York, New York · NCT07853690

  • A look at why Lewy body conditions cause visual hallucinations

    This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.

    Recruiting NYU Langone Health · New York, New York · NCT07849413

  • Virtual Reality Vision Testing for Metamorphopsia and Aniseikonia

    A portable virtual reality headset is tested to see if it can more reliably and conveniently measure visual distortions in people with metamorphopsia or aniseikonia.

    Recruiting NYU Langone Health · New York, New York · NCT07838181

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.